ATE550015T1 - Verfahren und zusammensetzung zur behandlung von rhinitis - Google Patents

Verfahren und zusammensetzung zur behandlung von rhinitis

Info

Publication number
ATE550015T1
ATE550015T1 AT05742190T AT05742190T ATE550015T1 AT E550015 T1 ATE550015 T1 AT E550015T1 AT 05742190 T AT05742190 T AT 05742190T AT 05742190 T AT05742190 T AT 05742190T AT E550015 T1 ATE550015 T1 AT E550015T1
Authority
AT
Austria
Prior art keywords
composition
treating rhinitis
rhinitis
compositions
nasal
Prior art date
Application number
AT05742190T
Other languages
English (en)
Inventor
Lena Pereswetoff-Morath
Anders Carlsson
Original Assignee
Biolipox Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolipox Ab filed Critical Biolipox Ab
Application granted granted Critical
Publication of ATE550015T1 publication Critical patent/ATE550015T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05742190T 2004-05-11 2005-05-06 Verfahren und zusammensetzung zur behandlung von rhinitis ATE550015T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/842,433 US20050255154A1 (en) 2004-05-11 2004-05-11 Method and composition for treating rhinitis
PCT/GB2005/001758 WO2005107711A2 (en) 2004-05-11 2005-05-06 Method and composition for treating rhinitis

Publications (1)

Publication Number Publication Date
ATE550015T1 true ATE550015T1 (de) 2012-04-15

Family

ID=34968224

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05742190T ATE550015T1 (de) 2004-05-11 2005-05-06 Verfahren und zusammensetzung zur behandlung von rhinitis

Country Status (25)

Country Link
US (3) US20050255154A1 (de)
EP (1) EP1771155B1 (de)
JP (1) JP4976283B2 (de)
CN (2) CN103271910B (de)
AT (1) ATE550015T1 (de)
AU (1) AU2005239866B2 (de)
BR (1) BRPI0510778B8 (de)
CA (1) CA2536728C (de)
CY (1) CY1112981T1 (de)
DK (1) DK1771155T3 (de)
EA (1) EA014752B1 (de)
ES (1) ES2395130T3 (de)
HK (1) HK1098960A1 (de)
HR (1) HRP20120484T1 (de)
IL (1) IL179012A (de)
ME (1) ME01436B (de)
MX (1) MXPA06013121A (de)
NO (1) NO335840B1 (de)
NZ (1) NZ550412A (de)
PL (1) PL1771155T3 (de)
PT (1) PT1771155E (de)
RS (1) RS52311B (de)
SI (1) SI1771155T1 (de)
WO (1) WO2005107711A2 (de)
ZA (1) ZA200608407B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060484A1 (es) 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
JP5846711B2 (ja) 2005-06-09 2016-01-20 メダ アーベー 炎症性疾患の治療のための方法及び組成物
FR2900576B1 (fr) * 2006-05-03 2008-09-19 Centre Nat Rech Scient Procede de concentration extemporanee et reversible de liposomes.
US20090269393A1 (en) * 2006-06-12 2009-10-29 Jubliant Organosys Limited Chewable Bilayer Tablet Formulation
EP2219652B1 (de) * 2007-11-16 2012-04-25 Baylor College Of Medicine Phospholipid-zusammensetzungen und ihre verwendungen
WO2009148955A2 (en) * 2008-05-29 2009-12-10 Mdrna, Inc Multi-arm amines and uses thereof
PT2408453T (pt) 2009-03-17 2022-04-05 Nicox Ophthalmics Inc Formulações oftálmicas de cetirizina e métodos de utilização
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8524692B2 (en) * 2010-04-29 2013-09-03 Georgia Health Sciences University Research Institute, Inc. Ocular compositions containing dioleoylphosphatidylglycerol and uses thereof
JP2013535456A (ja) * 2010-07-28 2013-09-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器系及び炎症性疾患の治療用医薬組成物
CN102525921B (zh) * 2012-02-06 2013-08-07 西安力邦制药有限公司 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法
KR101475776B1 (ko) * 2012-08-24 2014-12-24 영진약품공업 주식회사 이중 포화 인지질을 포함하는 안정한 피부 외용 조성물
CN104887635B (zh) * 2015-05-20 2019-06-11 苏州东瑞制药有限公司 一种盐酸西替利嗪片及其制备工艺
CN113434592A (zh) * 2018-10-31 2021-09-24 创新先进技术有限公司 基于区块链的数据存证方法及装置、电子设备
CN114392235B (zh) * 2022-01-28 2023-06-27 成都大学 盐酸西替利嗪眼用脂质体、原位凝胶及其制备方法

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
US5141674A (en) * 1984-03-08 1992-08-25 Phares Pharmaceutical Research N.V. Methods of preparing pro-liposome dispersions and aerosols
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
GB8522964D0 (en) 1985-09-17 1985-10-23 Biocompatibles Ltd Aerosol
ES2036593T3 (es) 1986-06-12 1993-06-01 The Liposome Company, Inc. Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas.
WO1987007506A1 (en) 1986-06-12 1987-12-17 The Liposome Company, Inc. Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
SE8603812D0 (sv) 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US5422120A (en) * 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
JPH04505616A (ja) 1989-05-15 1992-10-01 ザ　リポソーム　カンパニー，インコーポレイテッド プロトン勾配によるリポソームへの薬剤の蓄積
US5498420A (en) * 1991-04-12 1996-03-12 Merz & Co. Gmbh & Co. Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
US5773457A (en) * 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
CA2176712C (en) * 1993-11-16 2000-05-23 Mantripragada Sankaram Synthetic membrane vesicles with controlled release of encapsulated biologically active substances
DE4341472A1 (de) 1993-12-02 1995-06-08 Schering Ag Verfahren zur Erhöhung der Stabilität von hydrophile Wirkstoffe enthaltenden Liposomensuspensionen
WO1995020944A1 (en) 1994-02-04 1995-08-10 Scotia Lipidteknik Ab Bilayer preparations
US6773719B2 (en) * 1994-03-04 2004-08-10 Esperion Luv Development, Inc. Liposomal compositions, and methods of using liposomal compositions to treat dislipidemias
EP0782571A1 (de) * 1994-09-23 1997-07-09 Arris Pharmaceutical Corporation Zusammensetzungen und methoden zur behandlung von mastzellen-vermittelten entzündungskrankheiten
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
US5783566A (en) * 1996-05-10 1998-07-21 California Institute Of Technology Method for increasing or decreasing transfection efficiency
EP0954318A1 (de) 1996-06-04 1999-11-10 The Procter & Gamble Company Nasenspray enthaltend ein intranasales steroid und ein antihistamin
TW497974B (en) 1996-07-03 2002-08-11 Res Dev Foundation High dose liposomal aerosol formulations
US5958378A (en) 1996-07-03 1999-09-28 Research Development Foundation High dose liposomal aerosol formulations containing cyclosporin A or budesonide
GB9625589D0 (en) * 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
WO1998048839A1 (en) 1997-04-30 1998-11-05 Warner-Lambert Company Topical nasal antiinflammatory compositions
GB2326337A (en) 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
AU8103198A (en) * 1997-07-04 1999-01-25 Torsana Osteoporosis Diagnostics A/S A method for estimating the bone quality or skeletal status of a vertebrate
DE69825495T2 (de) * 1998-12-23 2005-07-28 Idea Ag Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo
GR1003359B (el) 1998-12-24 2000-04-10 �.�. ����������� �.�.�.�. Λιποσωμιακο νιφλουμικο οξυ - νεο διαδερμικο αντιφλεγμονωδες φαρμακο [κεφαλη ψαροτουφεκου
US6613352B2 (en) * 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
AU2001260270A1 (en) * 2000-05-02 2001-11-12 Pharmacept Gmbh Liposomes containing active substances
ATE319428T1 (de) 2000-12-07 2006-03-15 Univ Utrecht Holding Bv Zusammensetzung zur behandlung von entzündlichen erkrankungen
US20030144336A1 (en) * 2001-08-27 2003-07-31 Pfizer Inc. Method of selecting nonsedating H1-antagonists
US20030054030A1 (en) * 2001-09-13 2003-03-20 Gary Gordon Method and compositions for the treatment of pruritus
DK1467762T3 (da) 2001-12-05 2006-04-10 Alcon Inc Anvendelse af en H1-antagonist og rimexolon som et sikkert steroid til behandling af rhinitis
WO2003097100A1 (en) 2002-05-15 2003-11-27 Engelbrecht, Edna Topical composition for the treatment of inflammatory conditions of the skin
EP1371362A1 (de) 2002-06-12 2003-12-17 Universiteit Utrecht Holding B.V. Zusammensetzung zur Behandlung entzündlicher Erkrankungen
US20040192601A1 (en) * 2002-08-02 2004-09-30 Silvia Corvera Lipid binding molecules and methods of use
JP2004168709A (ja) * 2002-11-20 2004-06-17 Nidek Co Ltd 抗アレルギー点眼点鼻用組成物
US20040198743A1 (en) * 2003-01-31 2004-10-07 Schering Corporation Methods for treating allergic skin and allergic ocular conditions using combinations of histamine receptor antagonists
US20050112199A1 (en) * 2003-09-24 2005-05-26 Mahesh Padval Therapeutic regimens for administering drug combinations
ES2574231T3 (es) 2003-10-15 2016-06-16 Syncore Biotechnology Co., Ltd Uso de liposomas catiónicos que comprenden paclitaxel
JP2005170923A (ja) * 2003-10-21 2005-06-30 Konica Minolta Medical & Graphic Inc リポソーム含有ｘ線造影剤およびその製造方法

Also Published As

Publication number Publication date
US20070026058A1 (en) 2007-02-01
JP2007537220A (ja) 2007-12-20
ME01436B (me) 2012-12-31
CN103271910B (zh) 2018-11-06
BRPI0510778B1 (pt) 2020-03-10
NO20064521L (no) 2007-02-06
WO2005107711A3 (en) 2006-03-16
HRP20120484T1 (hr) 2012-07-31
DK1771155T3 (da) 2012-07-09
EP1771155A2 (de) 2007-04-11
ES2395130T3 (es) 2013-02-08
AU2005239866A1 (en) 2005-11-17
RS52311B (en) 2012-12-31
NZ550412A (en) 2010-08-27
HK1098960A1 (en) 2007-08-03
IL179012A0 (en) 2007-03-08
NO335840B1 (no) 2015-03-02
CN1984643A (zh) 2007-06-20
EP1771155B1 (de) 2012-03-21
JP4976283B2 (ja) 2012-07-18
PL1771155T3 (pl) 2012-08-31
US20180104238A9 (en) 2018-04-19
SI1771155T1 (sl) 2012-09-28
IL179012A (en) 2014-11-30
WO2005107711A2 (en) 2005-11-17
CN103271910A (zh) 2013-09-04
AU2005239866B2 (en) 2010-03-04
CA2536728C (en) 2011-02-01
US20130039969A1 (en) 2013-02-14
ZA200608407B (en) 2007-12-27
CY1112981T1 (el) 2016-04-13
US9980959B2 (en) 2018-05-29
MXPA06013121A (es) 2007-05-16
PT1771155E (pt) 2012-05-15
BRPI0510778B8 (pt) 2021-05-25
EA200602092A1 (ru) 2007-06-29
EA014752B1 (ru) 2011-02-28
BRPI0510778A (pt) 2007-11-20
US20050255154A1 (en) 2005-11-17
CA2536728A1 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
ATE550015T1 (de) Verfahren und zusammensetzung zur behandlung von rhinitis
DE602004031462D1 (de) Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
BRPI0415858A (pt) compostos de medicamentos terapêuticos modificados por tocoferol
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
ATE429156T1 (de) Nahrungsergänzung zur behandlung von makula degeneration
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
DE602004012816D1 (de) Selbstexpandierbarer Stent und Stenteinbringungssystem zur Behandlung von Gefässerkrankungen
DE602005017503D1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
DE60303238D1 (de) Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
DE602004022036D1 (de) Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen
ATE539754T1 (de) Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen
ATE538790T1 (de) Scopolamin für die behandlung von depression und ängstlichkeit
ATE460166T1 (de) Chinazolinderivate und ihre verwendung bei der behandlung von thrombocythämie
DE602004017283D1 (de) Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür
CY1106409T1 (el) Παραγωγα κινολινης
ATE444754T1 (de) Verwendung von tyrosinkinase-inhibitoren zur behandlung inflammatorischer prozesse
DE602004029993D1 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit
NO20060655L (no) 2-alkyliden-19-Nor-vitamin D derivater for behandling av osteofeni eller osteoporose hos hannkjonn
ATE413171T1 (de) Pharmazeutische zusammensetzungen mit ascorbinsäure zur behandlung von pilz- superinfektionen und pilz-rezidiven
FR2860234B1 (fr) Nouveaux derives 666 du thioxylose
ATE545421T1 (de) Pharmazeutisches präparat zur behandlung von parasitären tropenkrankheiten enthaltend diminazen-di-aceturat
ATE441461T1 (de) Mittel zur behandlung von infektionen
DE502007006951D1 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
ATE337790T1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen
ATE454144T1 (de) Behandlung von malignen neoplasien